|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 475-483, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
IM Rebeyka, RA Axford-Gatley, BG Bush, PJ del Nido, DA Mickle, AD Romaschin and GJ Wilson
The production and prevention of calcium paradox injury in myocardium was
studied in a canine model of cardiopulmonary bypass with multidose,
moderately hypothermic, crystalloid cardioplegic solution. During 4 1/2
hours of global ischemia, three groups of six dogs each received one of
three histidine-buffered cardioplegic solutions (500 ml initially and 250
ml every 30 minutes) at 27 degrees C. Group 1 cardioplegic solution was
calcium free, group 2 solution contained a trace amount of calcium chloride
(70 mumols /L), and group 3 cardioplegic solution was calcium free but
contained diltiazem (150 micrograms/kg body weight). Left ventricular
function measured as percent control of developed pressure revealed
significantly greater (p less than 0.05) recovery in groups 2 and 3.
Triphenyltetrazolium chloride staining showed 35% +/- 9% (mean +/- standard
error) of heart mass necrosis in group 1 versus 0% and 0.5% +/- 0.4% in
groups 2 and 3, respectively (p less than 0.001). Electron microscopy
revealed ultrastructural changes characteristic of calcium paradox injury
in group 1 myocardium. Calcium paradox injury was produced in an in vivo
model of global myocardial ischemia and multidose cardioplegia despite
moderate hypothermia and non-coronary collateral flow. The addition of
either trace levels of calcium or diltiazem to the cardioplegic solution
was effective in preventing this injury.
ARTICLES
Calcium paradox in an in vivo model of multidose cardioplegia and moderate hypothermia. Prevention with diltiazem or trace calcium levels
Department of Surgery, Toronto General Hospital, Ontario, Canada.
This article has been cited by other articles:
![]() |
M. Ruel, T. A. Khan, P. Voisine, C. Bianchi, and F. W. Sellke Vasomotor dysfunction after cardiac surgery Eur J Cardiothorac Surg, November 1, 2004; 26(5): 1002 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, H. Kuroda, N. Takemoto, S. Ohgi, and T. Mori Risk of low calcium and high magnesium in continuous warm hyperkalemic cardioplegia Ann. Thorac. Surg., October 1, 1999; 68(4): 1295 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ohkado, H. Cao-Danh, K. E. Sommers, and P. J. del Nido Evaluation of highly buffered low-calcium solution for long-term preservation of the heartComparison with University of Wisconsin solution J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 762 - 771. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |